Home › Thrombocytopenia › North Carolina
Thrombocytopenia clinical trials in North Carolina
4 studies for Thrombocytopenia are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
- Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07447817Neonatal Platelet Transfusion Threshold Trial
- Duke University, Durham
RecruitingHealthy volunteers welcome
1 Hour – 48 Hours · All sexes · Updated Mar 25, 2026 · NCT06676904A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Duke University, Durham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT05980806From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.